Why Did META, MRNA, OKTA Stocks Surge To 52-Week Highs Today?
Why Did META, MRNA, OKTA Stocks Surge To 52-Week Highs Today? Yahoo Finance
Covered in this story
What has happened since
- Meta Platforms is down 11.3% since this was published, 26 days ago.
- Moderna is up 24.3% since this was published, 26 days ago.
- Okta is down 6.0% since this was published, 26 days ago.
Price move measured from the close nearest publication to the latest quote.
Analyst targets on Meta Platforms
- UBS: $738 → $884 by Oct 2027 · Buy via MarketBeat
- Goldman Sachs: $738 → $762 by Oct 2027 · Buy via MarketBeat
- Goldman Sachs: $763 → $860 by Oct 2027 · Buy via TipRanks
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Member calls on Meta Platforms
Members have posted price targets on $META, scored on how close they land.
See the calls →Dalsna Finance is currently tracking 61 stories mentioning Meta Platforms, the earliest published 2 May 2012.
Summary aggregated from Yahoo Finance's public RSS feed. The full reporting belongs to Yahoo Finance — please read it on their site.